Date |
Report No. |
Title |
Date June 27, 2011 |
Report No. GAO-11-632 |
Title
United States Government Accountability Office GAO
June 2011 Report to Congressional Requesters INFLUENZA PANDEMIC Lessons from the H1N1 Pandemic Should Be Incorporated into Future Planning GAO-11-632 June 2011 INFLUENZA PANDEMIC
Accountability • Integrity • Reliability Lessons from the H1N1 Pandemic Should Be Incorporated into Future Planning
Highlights of GAO-11-632, a report to congressiona... |
Date Nov. 24, 2009 |
Report No. GAO-10-73 |
Title
United States Government Accountability Office GAO
November 2009 Report to the Chairman, Committee on Homeland Security, House of Representatives INFLUENZA PANDEMIC Monitoring and Assessing the Status of the National Pandemic Implementation Plan Needs Improvement GAO-10-73 November 2009 INFLUENZA PANDEMIC Highlights
Highlights of GAO-10-73, a report to the Chairman, Committee on Homeland Security,... |
Date Oct. 31, 2007 |
Report No. GAO-08-27 |
Title
United States Government Accountability Office GAO
October 2007 Report to the Committee on Oversight and Government Reform, House of Representatives INFLUENZA VACCINE Issues Related to Production, Distribution, and Public Health Messages GAO-08-27 October 2007 INFLUENZA VACCINE Highlights
Highlights of GAO-08-27, a report to the Committee on Oversight and Government Reform, House of Representative... |
Date June 29, 2007 |
Report No. GAO-07-787R |
Title
United States Government Accountability Office Washington, DC 20548 June 29, 2007 The Honorable Carl Levin Chairman The Honorable John McCain Ranking Member Committee on Armed Services United States Senate The Honorable Ike Skelton Chairman The Honorable Duncan L. Hunter Ranking Member Committee on Armed Services House of Representatives Subject: Military Health: DOD’s Vaccine Healthcare Centers... |
Date Nov. 4, 2005 |
Report No. GAO-06-221T |
Title
United States Government Accountability Office GAO
For Release on Delivery Expected at 10:00 a.m. EST Friday, November 4, 2005 Testimony Before the Committee on Government Reform, House of Representatives INFLUENZA PANDEMIC Applying Lessons Learned from the 2004–05 Influenza Vaccine Shortage
Statement for the Record by Marcia Crosse Director, Health Care GAO-06-221T November 4, 2005 INFLUENZA PA... |
Date Sept. 30, 2005 |
Report No. GAO-05-984 |
Title
United States Government Accountability Office GAO
September 2005 Report to Congressional Committees INFLUENZA VACCINE Shortages in 2004–05 Season Underscore Need for Better Preparation GAO-05-984 September 2005 INFLUENZA VACCINE Highlights
Highlights of GAO-05-984, a report to the Committee on Government Reform, House of Representatives, and the Committee on Homeland Security and Governmental A... |
Date June 30, 2005 |
Report No. GAO-05-863T |
Title
United States Government Accountability Office GAO
For Release on Delivery Expected at 10:00 a.m. EDT Thursday, June 30, 2005 Testimony Before the Committee on Government Reform, House of Representatives INFLUENZA PANDEMIC Challenges in Preparedness and Response
Statement of Marcia Crosse Director, Health Care GAO-05-863T June 30, 2005 INFLUENZA PANDEMIC Highlights
Highlights of GAO-05-863T, a tes... |
Date May 26, 2005 |
Report No. GAO-05-760T |
Title
United States Government Accountability Office GAO
For Release on Delivery Expected at 10:00 a.m. EDT Thursday, May 26, 2005 Testimony Before the Subcommittee on Health, Committee on Energy and Commerce, House of Representatives INFLUENZA PANDEMIC Challenges Remain in Preparedness
Statement of Marcia Crosse Director, Health Care GAO-05-760T May 26, 2005 INFLUENZA PANDEMIC Highlights
Highlights of ... |
Date March 31, 2005 |
Report No. GAO-05-399 |
Title
United States Government Accountability Office GAO
March 2005 Report to Congressional Requesters HHS Efforts to Research and Inform the Public about Nonoxynol-9 and HIV GAO-05-399 a March 2005 HHS Highlights
Highlights of GAO-05-399, a report to congressional requesters Accountability Integrity Reliability Efforts to Research and Inform the Public about Nonoxynol-9 and HIV Why GAO Did This Study
P... |
Date March 8, 2005 |
Report No. GAO-05-214 |
Title
United States Government Accountability Office GAO
March 2005 Report to Congressional Requesters HOMELAND SECURITY Much Is Being Done to Protect Agriculture from a Terrorist Attack, but Important Challenges Remain GAO-05-214 a March 2005 HOMELAND SECURITY Highlights
Highlights of GAO-05-214, a report to congressional requesters Accountability Integrity Reliability Much Is Being Done to Protect Agr... |
Date Nov. 18, 2004 |
Report No. GAO-05-177T |
Title
United States Government Accountability Office GAO
For Release on Delivery Expected at 9:30 a.m. EST Thursday, November 18, 2004 Testimony Before the Subcommittee on Health and the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives FLU VACCINE Recent Supply Shortages Underscore Ongoing Challenges
Statement of Janet Heinrich Director, Health Car... |
Date Sept. 28, 2004 |
Report No. GAO-04-1100T |
Title
United States Government Accountability Office GAO
For Release on Delivery Expected at 10:00 a.m. EDT Tuesday, September 28, 2004 Testimony Before the Special Committee on Aging, U.S. Senate INFECTIOUS DISEASE PREPAREDNESS Federal Challenges in Responding to Influenza Outbreaks
Statement of Janet Heinrich Director, Health Care—Public Health Issues GAO-04-1100T September 28, 2004 INFECTIOUS DISEA... |
Date Sept. 20, 2002 |
Report No. GAO-02-445 |
Title
United States General Accounting Office GAO
September 2002 Report to Congressional Requesters ANTHRAX VACCINE GAO’s Survey of Guard and Reserve Pilots and Aircrew GAO-02-445 Contents Letter
Results in Brief Background Scope and Methodology The Anthrax Threat Has Been Limited and Stable Since 1990 How the Anthrax Program Affected Aircrew Members’ Decisions to Change Military Status The Anthrax ... |
Date Sept. 17, 2002 |
Report No. GAO-02-1105T |
Title
United States General Accounting Office GAO Testimony
Before the Subcommittee on Public Health, Committee on Health, Education, Labor, and Pensions, U.S. Senate For Release on Delivery Expected at 2:30 p.m. Tuesday, September 17, 2002 CHILDHOOD VACCINES Challenges in Preventing Future Shortages
Statement of Janet Heinrich Director, Health Care—Public Health Issues GAO-02-1105T Mr. Chairman and M... |
Date Sept. 13, 2002 |
Report No. GAO-02-987 |
Title
United States General Accounting Office GAO
September 2002 Report to Congressional Requesters CHILDHOOD VACCINES Ensuring an Adequate Supply Poses Continuing Challenges GAO-02-987 Contents Letter
Results in Brief Background Shortages Prompt Actions to Reduce Immunization Requirements Problems Causing Shortages Largely Resolved, but Shortages Could Recur No Clear Path Yet to Resolve Ongoing Supply ... |
Date May 23, 2002 |
Report No. GAO-02-777T |
Title
United States General Accounting Office GAO Testimony
Before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives For Release on Delivery Expected at 10:00 a.m. Thursday, May 23, 2002 MEDICARE Use of Preventive Services is Growing but Varies Widely
Statement of Janet Heinrich Director, Health Care—Public Health Issues GAO-02-777T Mr. Chairm... |
Date April 10, 2002 |
Report No. GAO-02-422 |
Title
United States General Accounting Office GAO
April 2002 Report to the Chairman, Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives MEDICARE Beneficiary Use of Clinical Preventive Services GAO-02-422 Contents Letter
Results in Brief Background Use of Preventive Services Is Growing but Varies Widely Efforts Under Way to Increase Use of Some Preven... |
Date May 30, 2001 |
Report No. GAO-01-786T |
Title
United States General Accounting Office GAO
For Release on Delivery Expected at 9:30 a.m. in Portland, Oregon Wednesday, May 30, 2001 Testimony
Before the Special Committee on Aging, U.S. Senate FLU VACCINE Steps Are Needed to Better Prepare for Possible Future Shortages
Statement of Janet Heinrich Director, Health Care-Public Health Issues GAO-01-786T Chairman Craig, Ranking Member Breaux, and Se... |
Date May 15, 2001 |
Report No. GAO-01-624 |
Title
United States General Accounting Office GAO
May 2001 Report to Congressional Requesters FLU VACCINE Supply Problems Heighten Need to Ensure Access for High-Risk People GAO-01-624 Contents Letter
Results in Brief Background Manufacturing Problems Caused Temporary Shortages and Spikes in Price Distribution of Vaccine Does Not Ensure Priority to High-Risk Individuals HHS Has Initiatives Under Way to ... |
Date Dec. 13, 2000 |
Report No. GAO-01-21 |
Title
United States General Accounting Office GAO
December 2000 Report to Congressional Requesters STATE DEPARTMENT Serious Problems in the Anthrax Vaccine Immunization Program GAO-01-21 United States General Accounting Office Washington, D.C. 20548 Le er t December 13, 2000 The Honorable Jesse A. Helms Chairman, Committee on Foreign Relations United States Senate The Honorable Benjamin A. Gilman Chairm... |
Date Oct. 27, 2000 |
Report No. GAO-01-4 |
Title
United States General Accounting Office GAO
October 2000 Report to Congressional Requesters INFLUENZA PANDEMIC Plan Needed for Federal and State Response GAO-01-4 Contents Letter Appendix Tables
Appendix I: Comments From the Department of Health and Human Services 3 30 8 10 11 16 19 Table 1: Annual Vaccine Production Process Table 2: Months for Newly Detected Influenza Viruses to Reach the United ... |
Date Oct. 11, 2000 |
Report No. GAO-01-92T |
Title
United States General Accounting Office GAO
For Release on Delivery Expected at 10:00 a.m. Wednesday, October 11, 2000 Testimony
Before the Committee on Government Reform, House of Representatives ANTHRAX VACCINE Preliminary Results of GAO’s Survey of Guard/Reserve Pilots and Aircrew Members
Statement of Kwai-Cheung Chan, Director Applied Research and Methods GAO-01-92T Mr. Chairman and Members ... |
Date April 14, 2000 |
Report No. T-NSIAD-00-140 |
Title
United States General Accounting Office GAO
For Release on Delivery Expected at 1:00 p.m., CDT Friday, April 14, 2000 Testimony
Before the Subcommittee on Personnel, Committee on Armed Services, U.S. Senate CONTRACT MANAGEMENT DOD’s Anthrax Vaccine Manufacturer Will Continue to Need Financial Assistance
Statement of David E. Cooper, Associate Director Defense Acquisition Issues National Security... |
Date March 1, 2000 |
Report No. NSIAD-00-95 |
Title
United States General Accounting Office GAO
March 2000 Report to Congressional Requesters GLOBAL HEALTH Summary of Conference on Immunization in Developing Countries GAO/NSIAD-00-95 Contents Letter Appendixes
Appendix I: Conference Agenda and Profiles of Participants Appendix II: GAO Contacts and Staff Acknowledgments 3 12 19 Abbreviations Hib WHO Haemophilus influenzae type B World Health Organiz... |
Date Nov. 4, 1999 |
Report No. NSIAD-00-54R |
Title
United States General Accounting Washington, DC 20548 Office National Security and International Affairs Division B-284044 November 4, 1999 The Honorable Steve Buyer Chairman, Subcommittee on Military Personnel Committee on Armed Services House of Representatives Subject: Summary Vaccine of GAO’s Findinas on the Safetv and Efficacv of the Anthrax Dear Mr. Chairman: Concerns have been raised abou... |
Date Oct. 22, 1999 |
Report No. NSIAD-00-36 |
Title
United States General Accounting Office GAO
October 1999 Report to the Chairman and Ranking Minority Member, Committee on Veterans’ Affairs, U.S. Senate MEDICAL READINESS DOD Faces Challenges in Implementing Its Anthrax Vaccine Immunization Program GAO/NSIAD-00-36 Contents Letter Appendixes
Appendix I: Appendix II: Scope and Methodology Packaging and Shipping Protocol 3 38 41 43 48 53 54 Appendi... |
Date Oct. 20, 1999 |
Report No. T-NSIAD-00-49 |
Title
United States General Accounting Office GAO
For Release on Delivery Expected at 10:00 a.m., EDT Wednesday, October 20, 1999 Testimony
Before the Subcommittees on Military Procurement and on Military Research and Development, Committee on Armed Services, House of Representatives CHEMICAL AND BIOLOGICAL DEFENSE Observations on Actions Taken to Protect Military Forces
Statement of Norman J. Rabkin, D... |
Date Oct. 15, 1999 |
Report No. NSIAD-00-4 |
Title
United States General Accounting Office GAO
October 1999 Report to Congressional Requesters GLOBAL HEALTH Factors Contributing to Low Vaccination Rates in Developing Countries GAO/NSIAD-00-4 Contents Letter Appendixes
Appendix I: Objectives, Scope, and Methodology 3 22 24 26 31 Appendix II: Comments From the Centers for Disease Control and Prevention Appendix III: Comments From the U.S. Agency for... |
Date Oct. 12, 1999 |
Report No. T-NSIAD-00-48 |
Title
United States General Accounting Office GAO
For Release on Delivery Expected at 1:00 p.m., EDT Tuesday, October 12, 1999 Testimony
Before the Committee on Government Reform, House of Representatives ANTHRAX VACCINE Safety and Efficacy Issues
Statement of Kwai-Cheung Chan, Director, Special Studies and Evaluations, National Security and International Affairs Division GAO/T-NSIAD-00-48 Mr. Chairman ... |
Date July 21, 1999 |
Report No. T-NSIAD-99-226 |
Title
United States General Accounting Office GAO
For Release on Delivery Expected at 10:00, a.m., EDT Wednesday, July 21, 1999 Testimony
Before the Subcommittee on National Security, Veterans’ Affairs, and International Relations, Committee on Government Reform, House of Representatives MEDICAL READINESS Issues Concerning the Anthrax Vaccine
Statement of Kwai-Cheung Chan, Director Special Studies and... |
Date June 30, 1999 |
Report No. T-NSIAD-99-214 |
Title
United States General Accounting Office GAO
For Release on Delivery Expected at 10:00 a.m., EDT Wednesday, June 30, 1999 Testimony
Before the Subcommittee on National Security, Veterans Affairs, and International Relations, Committee on Government Reform, House of Representatives CONTRACT MANAGEMENT Observations on DOD’s Financial Relationship With the Anthrax Vaccine Manufacturer
Statement of L... |
Date April 29, 1999 |
Report No. T-NSIAD-99-148 |
Title
United States General Accounting Office GAO
For Release on Delivery Expected at 10:00 a.m., EST Thursday, April 29, 1999 Testimony
Before the Subcommittee on National Security, Veterans’ Affairs, and International Relations, Committee on Government Reform, House of Representatives MEDICAL READINESS Safety and Efficacy of the Anthrax Vaccine
Statement of Kwai-Cheung Chan, Director, Special Studie... |
Date May 20, 1998 |
Report No. T-NSIAD-98-183 |
Title
United States General Accounting Office GAO
Release on Delivery Expected at 10:00 a.m., EDT Wednesday, May 20, 1998 Testimony
Before the Committee on International Relations, House of Representatives INFECTIOUS DISEASES Analysis of Eradication or Elimination Estimates
Statement of Benjamin F. Nelson, Director, International Relations and Trade Issues, National Security and International Affairs Di... |
Date April 23, 1998 |
Report No. NSIAD-98-114 |
Title
United States General Accounting Office GAO
April 1998 Report to the Chairman, Committee on International Relations, House of Representatives INFECTIOUS DISEASES Soundness of World Health Organization Estimates for Eradication or Elimination GAO/NSIAD-98-114 GAO United States General Accounting Office Washington, D.C. 20548 National Security and International Affairs Division B-279440 April 23, 19... |
Date March 17, 1998 |
Report No. T-NSIAD-98-83 |
Title
United States General Accounting Office GAO
For Release on Delivery Expected at 10:00 a.m., EST Tuesday, March 17, 1998 Testimony
Before the Committee on Veterans’ Affairs, U.S. Senate CHEMICAL AND BIOLOGICAL DEFENSE Observations on DOD’s Plans To Protect U.S. Forces
Statement of Mark E. Gebicke, Director, Military Operations and Capabilities Issues, National Security and International Affairs... |
Date Aug. 1, 1997 |
Report No. HEHS-97-136R |
Title
GAO United States General Acconnting Office Washington, D.C. 20648 Health, Education and Human Semites Division : B-277401 August 1, 1997 The Honorable Dale Bumpers The Honorable Ron Wyden United States Senate The Honorable Scott Klug House of Representatives Subject: CDC’s National Immunization Program: Methods Used to Identifv Pockets of Under-immunized Children Not Evaluated The Centers for D... |
Date Jan. 23, 1997 |
Report No. HEHS-97-36 |
Title
United States General Accounting Office GAO
January 1997 Report to Congressional Requesters HEALTH CARE SERVICES How Continuing Care Retirement Communities Manage Services for the Elderly GAO/HEHS-97-36 GAO United States General Accounting Office Washington, D.C. 20548 Health, Education, and Human Services Division B-274820 January 23, 1997 The Honorable Thomas J. Bliley, Jr. Chairman, Committee o... |
Date May 1, 1996 |
Report No. T-NSIAD-96-154 |
Title
United States General Accounting Office GAO
For Release on Delivery Expected at 3:00 P.M., EST Wednesday May 1, 1996 Testimony
Before the Presidential Advisory Committee on Gulf War Veterans’ Illnesses CHEMICAL AND BIOLOGICAL DEFENSE Emphasis Remains Insufficient to Resolve Continuing Problems
Statement of Mark E. Gebicke, Director, Military Operations and Capabilities Issues, National Security ... |
Date March 29, 1996 |
Report No. NSIAD-96-103 |
Title
United States General Accounting Office GAO
March 1996 Report to Congressional Requesters CHEMICAL AND BIOLOGICAL DEFENSE Emphasis Remains Insufficient to Resolve Continuing Problems G A O years
1921 - 1996 GAO/NSIAD-96-103 GAO United States General Accounting Office Washington, D.C. 20548 National Security and International Affairs Division B-258889 March 29, 1996 The Honorable Herbert H. Bateman... |
Date March 12, 1996 |
Report No. T-NSIAD-96-123 |
Title
United States General Accounting Office GAO
For Release on Delivery Expected at 3:00 p.m., EDT Tuesday, March 12, 1996 Testimony
Before the Committee on National Security, Subcommittee on Military Research and Development, House of Representatives CHEMICAL AND BIOLOGICAL DEFENSE Emphasis Remains Insufficient to Resolve Continuing Problems
Statement of Mark E. Gebicke, Director, Military Operations... |
Date June 15, 1995 |
Report No. PEMD-95-22 |
Title
United States General Accounting Office GAO
. June 1995 Report to Cbngressional Requesters c VACCINES FOR CHILDREN Reexamination of Program Goals and Implementation ‘ Needed to Ensure Vaccination $ GAO/PEMD-96-22 Program Evaluation and Methodology Division B-261272 June 15,1995 The Honorable Dale Bumpers United States Senate The Honorable Scott Klug The Honorable Ron Wyden House of Representativ... |
Date June 15, 1995 |
Report No. T-PEMD-95-23 |
Title
United States General Accounting Office GAO
Par Release on Delivery Expected at lo:30 a.m. EST Tlmrsday June 15.1995 Testimony
Before the Subcommittee on Health and Environment, Committee on Commerce, House of Representatives VACCINES FOR CHILDREN Refocusing the Program’ Goal s and Implementation
Statement of Kwai-Cheung Chan Director for Program Evaluation in Physical Systems Areas Program Eval... |
Date June 8, 1995 |
Report No. PEMD-95-14 |
Title
GAO United States General Accounting Office Washington, D-C. 20548 Program Evaluation and Methodology Division ___I.--._~- -.--._-. B-254782 June 8, 1995 The Honorable John H. Chafee Chairman, Subcommittee on Medicaid and Health Care for Low-Income Families Committee on Finance United States Senate The Honorable Judd Gregg Chairman, Subcommittee on Aging Committee on Labor and Human Resources Uni... |
Date May 26, 1995 |
Report No. HEHS-95-114 |
Title
United States General Accounting Office GAO
May 1995 Report to the Ranking Minority Member, Subcommittee on Human Resources, Committee on Ways and Means, House of Representatives FOSTER CARE Health Needs of Many Young Children Are Unknown and Unmet GAO/HEHS-95-114 GAO United States General Accounting Office Washington, D.C. 20548 Health, Education, and Human Services Division B-259319 May 26, 1995... |
Date May 4, 1995 |
Report No. T-PEMD-95-21 |
Title
United States General Accounting Office GAO
For Release on Delivery Expected at 9:30 a.m. EST Thursday May 4, 1995 Testimony
Before the Cornmittee on Finance United States Senate VACCINES FOR CHILDREN Barriers to Immunization
Statement of Kwai-Cheung Chan Director for Program Evaluation in Physical Systems Areas Program Evaluation and Methodology Division ; GAO/T-PEMD-95-21 [ Mr. Chairman and Memb... |
Date July 21, 1994 |
Report No. T-PEMD-94-29 |
Title
United States General Accounting Office GAO
For Release on Delivery Expected at 2:00 p.m. Thursday July 21, 1994 Testimony
Before the Subcommittee on Labor, Health, Human Services, and Education Committee on Appropriations United States Senate VACCINES FOR CHTLDREN Major Implementation Hurdles Remain
Statement of Kwai-Cheung Chan Director of Program Evaluation in Physical Systems Areas Program Eva... |
Date July 18, 1994 |
Report No. PEMD-94-28 |
Title
United States General Accounting Office GAO
July 1994 Report to Congressional Requesters VACCINES FOR CHILDREN CriticaI :Issuesin Design and ImplementBtion GAO United States General Accounting Office Wash&@n, D.C. 20548 Program Evaluation and Methodology Division B-257864 July l&1994 The Honorable Dale Bumpers The Honorable John Danforth United States Senate The Honorable Scott Klug The Honorable ... |
Date Aug. 4, 1993 |
Report No. HRD-93-62 |
Title
United States General Accounting Office GAO
August 1993 Report to the Chairman, Committee on Finance, US. Senate PREVENTIVE HEALTH CARE FOR CHILDREN Experience From Selected Foreign Countries GAO/HRD-93-62 GAO United States General Accounting Offke Washington, D.C. 20648
Human Resources Division B-250464 August 4,1993
The Honorable Daniel P. Moynihan Chairman, Committee on Finance United States Se... |
Date May 7, 1993 |
Report No. HRD-93-67 |
Title
- GAO
Mity l!)!f;S .- I1nit.d States (~mwral Accounting Office Report to the Chairman, Subcommittee on Health and the Environment, Committee on Energy and Commerce, House of Representatives MEDICAID HealthPASS: An Evaluation of a Managed Care Program for Certain Philadelphia Ret ---- GAO United States General Accounting Office Washington, D.C. 20648 Human Resources Division B-262699 May 7,1993 The... |
Date March 24, 1993 |
Report No. HRD-93-41 |
Title
~ M;lrx~ll I!)!):{ / CHILDHOOD IMMUNIZATION Opportunities to Improve Immunization Rates at Lower Cost Ml II
148883 (;i\O/IlHI)--!JY-4 1 Human Resources Division B-252356 March 24, 1993 The Honorable Daniel P. Moynihan Chairman, Committee on Finance United States Senate Dear Mr. Chairman: This report responds to your request to examine possible ways to reduce Medicaid costs for immunizing children.... |